On ECHEMI
Home > Drugs > Furen Pharmaceutical Group Co., Ltd.
Furen Pharmaceutical Group Co., Ltd.
  • Founded in:

    1997-01-22
  • Country:

    China China
  • Address:

    No. 1 Tongyuan Road, Luyi County Industrial Cluster Area
  • Tax NO.:

    9141000017569469XJ
  • Registered Funds:

    400 million yuan
  • Email:

Related Drugs
Compound Sodium Chloride Injection
This product is a compound preparation containing 0.85% sodium chloride, 0.03% potassium chloride and 0.033% calcium chloride.
Name Description Content CAS NO. Registered Holders
Sodium chloride

Maintain normal blood and extracellular fluid volume and osmotic pressure in the human body; sodium and chloride are important electrolytes in the body, accounting for the main part of plasma cations and total osmotic pressure.

More

Maintain normal blood and extracellular fluid volume and osmotic pressure in the human body; sodium and chloride are important electrolytes in the body, accounting for the main part of plasma cations and total osmotic pressure.

0.85% 7647-14-5 43
Potassium chloride

Replenish potassium ions and participate in maintaining body fluid volume and electrolyte balance.

More

Replenish potassium ions and participate in maintaining body fluid volume and electrolyte balance.

0.03% 7447-40-7 39
Calcium chloride

Replenish calcium ions to help maintain body fluid volume and electrolyte balance.

More

Replenish calcium ions to help maintain body fluid volume and electrolyte balance.

0.033% 10043-52-4 29
Compound Sodium Chloride Injection
This product is a compound preparation containing 0.85% sodium chloride, 0.03% potassium chloride and 0.033% calcium chloride.
Name Description Content CAS NO. Registered Holders
Sodium chloride

Maintains normal blood and extracellular fluid volume and osmotic pressure in the human body; plays a decisive role in osmotic pressure

More

Maintains normal blood and extracellular fluid volume and osmotic pressure in the human body; plays a decisive role in osmotic pressure

0.85% 7647-14-5 43
Potassium chloride

Supplement a small amount of potassium ions to maintain the stability of body fluid volume and osmotic pressure

More

Supplement a small amount of potassium ions to maintain the stability of body fluid volume and osmotic pressure

0.03% 7447-40-7 39
Calcium chloride

Supplement a small amount of calcium ions to maintain the stability of body fluid volume and osmotic pressure

More

Supplement a small amount of calcium ions to maintain the stability of body fluid volume and osmotic pressure

0.033% 10043-52-4 29
Gastrodin injection
The main ingredient of this product is: Gastrodin. Its chemical name is: 4-hydroxyphenyl-β-D-pyranoglucoside.
Name Description Content CAS NO. Registered Holders
Gastrodin

Restores the imbalance between the excitation and inhibition processes of the cerebral cortex, and has central inhibitory effects such as sedation, hypnosis and analgesia

More

Restores the imbalance between the excitation and inhibition processes of the cerebral cortex, and has central inhibitory effects such as sedation, hypnosis and analgesia

62499-27-8 7
Metronidazole injection
The main ingredient of this product is: metronidazole.
Name Description Content CAS NO. Registered Holders
Metronidazole

Metronidazole has a strong antibacterial effect on most anaerobic bacteria, but has no effect on aerobic bacteria and facultative anaerobes. The antibacterial spectrum includes Bacteroides fragilis and other Bacteroides, Fusobacterium, Clostridium perfringens, Eubacterium, Veillonella, Peptococcus and Peptostreptococcus. Actinomycetes, Lactobacillus and Propionibacterium are resistant to this product. Its bactericidal concentration is slightly higher than the inhibitory concentration. This product can also inhibit the redox reaction of amoeba and break the nitrogen chain of the protozoa. In vitro tests have shown that when the drug concentration is 1-2 mg/L, the histolytica can undergo morphological changes in 6-20 hours and all are killed within 24 hours. When the concentration is 0.2 mg/L, the histolytica can be killed within 72 hours. This product has a strong effect of killing trichomonas, and its mechanism is unknown. It has a carcinogenic effect on some animals.

More

Metronidazole has a strong antibacterial effect on most anaerobic bacteria, but has no effect on aerobic bacteria and facultative anaerobes. The antibacterial spectrum includes Bacteroides fragilis and other Bacteroides, Fusobacterium, Clostridium perfringens, Eubacterium, Veillonella, Peptococcus and Peptostreptococcus. Actinomycetes, Lactobacillus and Propionibacterium are resistant to this product. Its bactericidal concentration is slightly higher than the inhibitory concentration. This product can also inhibit the redox reaction of amoeba and break the nitrogen chain of the protozoa. In vitro tests have shown that when the drug concentration is 1-2 mg/L, the histolytica can undergo morphological changes in 6-20 hours and all are killed within 24 hours. When the concentration is 0.2 mg/L, the histolytica can be killed within 72 hours. This product has a strong effect of killing trichomonas, and its mechanism is unknown. It has a carcinogenic effect on some animals.

443-48-1 39
Cefuroxime dry suspension
The main ingredient of this product is cefradine, and its chemical name is: (6R,7R)-7[(R)-2-amino-2-(1,4-cyclohexenyl)acetylamino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4,2,0]oct-2-ene-2-carboxylic acid.
Name Description Content CAS NO. Registered Holders
Cefradine

This product is a first-generation cephalosporin, which has good antibacterial effect on some strains of Gram-positive cocci such as non-penicillinase-producing and penicillinase-producing Staphylococcus aureus, coagulase-negative Staphylococci, group A hemolytic streptococci, Streptococcus pneumoniae and viridans streptococci. Anaerobic Gram-positive bacteria are mostly sensitive to this product, and Bacteroides fragilis is resistant to this product. Methicillin-resistant Staphylococci and Enterococci are resistant to this product. The effect of this product on Gram-positive and Gram-negative bacteria is similar to that of cephalexin. This product has a certain effect on gonococci and is also active against enzyme-producing gonococci; its activity against Haemophilus influenzae is poor.

More

This product is a first-generation cephalosporin, which has good antibacterial effect on some strains of Gram-positive cocci such as non-penicillinase-producing and penicillinase-producing Staphylococcus aureus, coagulase-negative Staphylococci, group A hemolytic streptococci, Streptococcus pneumoniae and viridans streptococci. Anaerobic Gram-positive bacteria are mostly sensitive to this product, and Bacteroides fragilis is resistant to this product. Methicillin-resistant Staphylococci and Enterococci are resistant to this product. The effect of this product on Gram-positive and Gram-negative bacteria is similar to that of cephalexin. This product has a certain effect on gonococci and is also active against enzyme-producing gonococci; its activity against Haemophilus influenzae is poor.

38821-53-3 27
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.